Insider buying last 90 days
$250Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Alt Aaron E director | Purchase | $250K |
From Form 4 filings, dated to when each was filed.
Nov 4 close
Keurig Dr Pepper's stock moved this week on third-quarter results, with adjusted diluted EPS rising 22% (and in one account 22.2%) to $0.66, as adjusted net sales climbed 70.1% to $7.3 billion, boosted by the JDE Peet's acquisition and legacy growth. Despite the earnings beat, shares fell as budget-conscious consumers pulled back on K-Cups, with softer demand in the U.S. coffee business cited as the driver of the decline; net sales also came in short of expectations even as refreshment beverages and energy drink share, now above 10%, were highlighted as strengths. TD Cowen maintained its Hold rating while raising its price target to $35 from $33, and a separate tracking service lifted its average 12-month target to $36.75 from $36.56, with a Buy consensus among the analysts it surveyed.
KDP closed at $36.79, up 5.9%, sitting above both its 50-day ($32.68) and 200-day ($30.12) averages, with one-month, three-month, six-month and one-year returns of 18.2%, 21.1%, 28.8% and 38.1% respectively. The GekkoIndex reads 46.8, in the Neutral zone. Price remains 9.9% below Gekko Fair Value of $40.82.
Looking ahead, the next earnings date falls on 23 February 2027, outside a typical 20-trading-day holding window. Over the last 90 days, smart money activity includes one open-market insider purchase valued at $250,247. Seasonality over the next 20 trading days has averaged a 1.5% gain across 5 years, rising in 3 of them. The 13 analysts covering the stock lean heavily toward Buy ratings, with a consensus target of $36.38, implying a -1.1% gap to current price.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Keurig Dr Pepper scores 5 supportive, 1 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive1 mixed0 headwinds
Above 50 and 200-day
Close $36.79 is above the 50-day ($32.68) and 200-day ($30.12) averages, and the 50-day is above the 200-day.
See the chart46.8, Neutral
Reading 46.8 is in the Neutral zone.
See the GekkoIndex9.9% below
Price is 9.9% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase.
See smart moneyReports in 110 days
Next report Feb 23, 2027, 110 days away — outside a typical 20-trading-day hold.
See earnings+1.5% on average
From this point in the calendar, the next 20 trading days averaged +1.5% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Keurig Dr Pepper closed at $36.79 on Nov 4, 2026, +38.1% over the past year, inside a 52-week range of $24.88 to $37.32.
Use the left and right arrow keys to read daily values.
Put KDP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Keurig Dr Pepper makes and sells a broad range of drinks and coffee equipment across the United States and other markets. It is widely recognized for its Keurig brewing systems and K-Cup pods, alongside a lineup of soda, juice and flavored beverage brands sold under many familiar labels.
The business runs through four segments. Coffee Systems covers brewers, pods and coffee blends, sold through retailers, outside distributors and the company's own website. Packaged Beverages makes and ships branded drinks and also produces beverages for private label and emerging brands, plus distribution work for partner labels. Beverage Concentrates supplies liquid concentrates and syrups for names such as Dr Pepper, Canada Dry, 7UP, Snapple, Bai, evian and several others. A separate Latin America unit produces sparkling and purified water, carbonated drinks and vegetable juice under brands including Peñafiel and Clamato. Customers span retailers, bottlers, restaurants, hotels, office coffee services and everyday consumers.
The company was established in 1981 and is headquartered in Burlington, Massachusetts. Its shares are listed on the NASDAQ under the ticker KDP.
Keurig Dr Pepper’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46.8, in the Neutral zone, down 0.2 points over five sessions.
Down 0.2 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 44 | −0.6% | −1.3% | ||
| Accumulation | 223 | +0.5% | +2.3% | ||
| Neutral (current zone) | 400 | +0.2% | −0.3% | ||
| Distribution | 29 | −1.4% | −2.2% | ||
| Selling | 1 | Too few readings yet | |||
Average KDP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Keurig Dr Pepper trades 9.9% below Gekko Fair Value of $40.82, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Keurig Dr Pepper shares are worth, recalculated every trading day.
$40.82
Gekko Fair Value, Nov 4, 2026
9.9% Undervalued
At the end of Aug 2026 the price was 23.7% below the estimate.
Insiders filed 1 open-market purchase in Keurig Dr Pepper worth $250K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$250Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Alt Aaron E director | Purchase | $250K |
From Form 4 filings, dated to when each was filed.
No trades in KDP were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Keurig Dr Pepper has been buying back its own shares.
From company filings.
Keurig Dr Pepper reports on Feb 23, 2027, before the open (110 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 23, 2027
Expected before the open, 110 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.57 est $0.54 | $7.31B est $7.23B | −2.4% |
| Feb 24, 2026 | $0.60 est $0.59 | $4.50B est $4.36B | +1.3% |
| Oct 27, 2025 | $0.54 est $0.54 | $4.31B est $4.15B | +6.2% |
| Jul 24, 2025 | $0.49 est $0.49 | $4.16B est $4.14B | −0.7% |
| Apr 24, 2025 | $0.42 est $0.38 | $3.64B est $3.57B | −2.2% |
| Feb 25, 2025 | $0.58 est $0.57 | $4.07B est $4.01B | −1.1% |
| Oct 24, 2024 | $0.51 est $0.51 | $3.89B est $3.92B | −5.8% |
| Jul 25, 2024 | $0.45 est $0.45 | $3.92B est $3.91B | +3.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Keurig Dr Pepper is $36.38, −1.1% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Wells Fargo | $40 | +8.7% |
| Nov 4 | RBC Capital | $42 | +14.2% |
| Nov 4 | UBS | $42 | +14.2% |
| Nov 4 | TD Cowen | $35 | −4.9% |
| Nov 4 | J.P. Morgan | $41 | +11.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Keurig Dr Pepper averaged +1.5% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.3% | 3 of 5 |
| Next 10 trading days | +0.2% | 3 of 5 |
| Next 15 trading days | +1.5% | 4 of 5 |
| Next 20 trading days | +1.5% | 3 of 5 |
| Next 30 trading days | +1.6% | 3 of 5 |
For scale, KDP’s typical 20-trading-day move in either direction is about 3.8%.
Keurig Dr Pepper’s market cap is $50.06B, with a P/E ratio of 36.1 and revenue of $20.09B over the last twelve months.
Coverage of Keurig Dr Pepper this week reads positive: 11 positive, 5 neutral and 3 negative headlines.
Keurig Dr Pepper’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| KOCoca-Cola | Neutral | 7.5% above |
| MNSTMonster Beverage | Neutral | 17.2% above |
| CCEPCoca-Cola Europacific Partners | Neutral | 6.3% above |
| COKECoca-Cola Consolidated | Neutral | 16.8% above |
| CELHCelsius | Neutral | 9.1% below |
| PRMBPrimo Brands | Neutral | 37.7% below |
A peer links to its own page where one exists.
Keurig Dr Pepper’s market cap is $50.06B at the Nov 4, 2026 close of $36.79, with 1.36B shares outstanding. The shares trade on a P/E ratio of 36.1.
The consensus analyst 12-month price target for Keurig Dr Pepper is $36.38, −1.1% from the last close. Of the 13 firms that rated the stock in the last 90 days, 11 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Keurig Dr Pepper is undervalued: the Nov 4, 2026 close of $36.79 is 9.9% below Gekko Fair Value of $40.82. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Keurig Dr Pepper is expected to report on Feb 23, 2027, before the market opens (110 days away). Analysts expect earnings of $0.69 per share on revenue of $7.66B. Keurig Dr Pepper beat the earnings estimate in 6 of its last 8 reports, moving 2.8% on average across the report.
Keurig Dr Pepper’s 52-week high is $37.32 and its 52-week low is $24.88; it closed at $36.79 on Nov 4, 2026, +38.1% over the past year. Over the last five years the shares peaked at $41.31 on Aug 18, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (trend, fair value, smart money, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.